LARA Diagnostics is a Swedish medical device and diagnostics company in the field of peripheral neurology.

We aim to provide an easy-to-use medical device for quantitative assessment of peripheral nerve injury. This will allow physicians and patients to monitor disease progression, identify early signs of injury and take action. The method is physiological and can detect peripheral sensory nerve injury – so called peripheral neuropathy (PN) – regardless the underlying cause.

The largest group of patients with PN are diabetics. Half of the world´s 380 million diabetics will acquire PN and interventions are most efficient in early stages of injury. Since PN is the most common underlying cause of amputation of diabetic patients, identification of patients at risk can support preventative healthcare and thus improve quality of care.

The project started in January 2013, through Clinical Innovation Fellowships, a program aiming to define needs and improve healthcare through innovation. The program is based on the successful “BioDesign Innovation Fellowships” at Stanford University in the US, and is run by Center for Technology in Health and Medicine (CTMH) – a collaboration between KTH, KI and Stockholms Läns Landsting.


LARA Diagnostics is collaborating with: